934765-89-6 Usage
Uses
Used in Pharmaceutical Synthesis:
[(1R)-3,3-dimethylcyclohexyl]amine hydrochloride is used as a reagent in the pharmaceutical industry for the synthesis of various drugs. Its unique stereochemistry allows for the creation of specific drug candidates with desired properties.
Used in Agrochemical Synthesis:
In the agrochemical industry, [(1R)-3,3-dimethylcyclohexyl]amine hydrochloride is employed as a reagent for the synthesis of agrochemicals, contributing to the development of effective products for agricultural applications.
Used in Organic Compound Synthesis:
[(1R)-3,3-dimethylcyclohexyl]amine hydrochloride is also used as a reagent in the synthesis of other organic compounds, leveraging its unique stereochemical properties to produce a range of chemical products.
Safety Precautions:
It is crucial to handle and store [(1R)-3,3-dimethylcyclohexyl]amine hydrochloride with proper safety measures, as it is classified as a hazardous substance. This ensures the protection of both the environment and the individuals involved in its use and production.
Check Digit Verification of cas no
The CAS Registry Mumber 934765-89-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,7,6 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 934765-89:
(8*9)+(7*3)+(6*4)+(5*7)+(4*6)+(3*5)+(2*8)+(1*9)=216
216 % 10 = 6
So 934765-89-6 is a valid CAS Registry Number.
934765-89-6Relevant academic research and scientific papers
As opioid receptor antagonists or inverse agonists of the novel compounds
-
Paragraph 0256; 0257, (2016/10/08)
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
NOVEL HETEROCYCLE COMPOUNDS
-
Page/Page column 47, (2009/04/24)
The present invention relates to novel compounds which are antagonist or inverse agonists at an opioid receptor. Such compounds are useful in the treatment of obesity and related diseases and/or conditions in mammals, particularly humans. Methods of making and using such compounds are also disclosed.
